Literature DB >> 9534092

Calcium antagonists and sympathetic nerve activation: are there differences between classes?

G Noll1, R R Wenzel, S Shaw, T F Lüscher.   

Abstract

ACTIONS OF THE SYMPATHETIC NERVOUS SYSTEM: The sympathetic nervous system is an important cardiovascular regulator, particularly during stress and exercise; its sympathetic nervous activity is regulated in centers in the brain stem and transmitted to organs and blood vessels that are innervated by sympathetic nerve endings. In the heart, the sympathetic nervous system increases heart rate and contractility. The effect of the sympathetic nervous system in different vascular beds depends on the degree of innervation, the distribution of postjunctional receptors and the effect of local mediators. Overactivation of the sympathetic nervous system may lead to hypertension and is involved in heart failure. The degree of sympathetic activation determines prognosis in heart failure. Hence, vasodilators ideally should also blunt sympathetic activity, or at least avoid activating it. DIFFERENCES AMONG CALCIUM ANTAGONISTS: Calcium antagonists are widely used for the treatment of hypertension and coronary artery disease. Their main mechanism of action is inhibition of L-type Ca2+ channels. Short-acting nifedipine leads to a marked increase in heart rate, sympathetic nerve activity and plasma catecholamines, similar to those induced by a cold pressor test. With long-acting nifedipine heart rate does not increase, but sympathetic nerve activity does increase. Other calcium antagonists have been less thoroughly investigated, but indirect evidence suggests differences between the different classes. Verapamil and diltiazem lower heart rate. Plasma noradrenalin measurements suggest that verapamil does not stimulate the sympathetic nervous system, but tends to suppress it. Second-generation dihydropyridines with longer duration of action do not increase heart rate; their effects on peripheral sympathetic nerve activity are not clear. Thus, in summary, the different classes of calcium antagonists differ with regard to their effects on sympathetic nerve activation. A decrease in heart rate and nerve activity might be beneficial for long-term prognosis, particularly in hypertension and heart failure.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9534092

Source DB:  PubMed          Journal:  J Hypertens Suppl        ISSN: 0952-1178


  5 in total

Review 1.  Treatment of hypertension in patients with diabetes mellitus : relevance of sympathovagal balance and renal function.

Authors:  Matthias Weck
Journal:  Clin Res Cardiol       Date:  2007-06-27       Impact factor: 5.460

Review 2.  The central mechanism underlying hypertension: a review of the roles of sodium ions, epithelial sodium channels, the renin-angiotensin-aldosterone system, oxidative stress and endogenous digitalis in the brain.

Authors:  Hakuo Takahashi; Masamichi Yoshika; Yutaka Komiyama; Masato Nishimura
Journal:  Hypertens Res       Date:  2011-08-04       Impact factor: 3.872

3.  Verapamil Blocks Scopolamine Enhancement Effect on Memory Consolidation in Passive Avoidance Task in Rats.

Authors:  Verónica Giménez De Béjar; María Caballero Bleda; Natalija Popović; Miroljub Popović
Journal:  Front Pharmacol       Date:  2017-08-23       Impact factor: 5.810

4.  Comparison of short-acting versus extended-release nifedipine: Effects on hemodynamics and sympathetic activity in patients with stable coronary artery disease.

Authors:  John D Parker; Matthew D' Iorio; John S Floras; Corey B Toal
Journal:  Sci Rep       Date:  2020-01-24       Impact factor: 4.379

5.  Changes in aortic pulse wave velocity in hypertensive postmenopausal women: comparison between a calcium channel blocker vs angiotensin receptor blocker regimen.

Authors:  Daniel Hayoz; Dion H Zappe; Marie A R Meyer; Inyoung Baek; Albert Kandra; Marie P Joly; Lucia Mazzolai; Erik Haesler; Daniel Periard
Journal:  J Clin Hypertens (Greenwich)       Date:  2012-09-12       Impact factor: 3.738

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.